检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:许庆文[1] 张桂菊[1] 田凤兰[2] 程刚[3]
机构地区:[1]济宁医学院附属医院眼科,272129 [2]济宁医学院附属医院检验科,272129 [3]济宁医学院附属医院内分泌科,272129
出 处:《临床眼科杂志》1995年第1期5-6,共2页Journal of Clinical Ophthalmology
摘 要:应用放射免疫法和比浊法测定31例单纯型糖尿病性视网膜病变患者分别服用25mg/日、50mg、日、100mg/日剂量的阿斯匹林各一个疗程对血浆血栓素水平和血小板聚集功能的影响。结果发现:50mg/日、100mg/日均可使患者的血浆血栓素水平显著下降;三种剂量的阿斯匹林对血小板聚集功能都有显著的抑制作用,但以50mg/日、100mg/日效果为佳。据此我们推茬50mg/日作为防治糖尿病性视网膜病变的最佳药物剂量。Thirty-one atients with background diabetic retinopathy were studied by radioimmunoassay and turbidity method to measure the effects of using aspirin 25mg/d、50mg/d、100mg/d、one by one for one course on the level of plasma thromboxane and the platelets aggregation functions. The results Showed that the use of 50mg/d、100mg/d of aspirin led to significant reduce of plasma thromboxane Level;The platelet aggregation functions were remarkbly restricted by using three various doses of aspirin;The effects were especially better by using 50mg/d or 100mg/d. We suggest that the 50mg/d of aspivin was the best dose to prevent and treat the diabetic retinopathy.
分 类 号:R774.130.5[医药卫生—眼科] R971.1[医药卫生—临床医学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28